SCHEMBL845015

SCHEMBL845015

CCc1ccccc1C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3cccnc3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
VNN1 O95497 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
FKBP1A P62942 1/20 0.41
ATM Q13315 1/20 0.40
PABPC1 P11940 1/20 0.39
PAX8 Q06710 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
HCRTR1 O43613 2/20 0.39
HCRTR2 O43614 2/20 0.39
ITGB1 P05556 2/20 0.39
ITGA4 P13612 2/20 0.39
ACE P12821 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845375 0.89 MAPK1 (0.46) ALDH1A1MEN1KMT2AKDM4EATM
SCHEMBL845431 0.88 TRPV1 (0.43) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL845376 0.87 ALDH1A1 (0.44) ALDH1A1VNN1MEN1KMT2AKDM4E
SCHEMBL845401 0.87 ALDH1A1 (0.45) ALDH1A1VNN1MEN1KMT2AKDM4E
SCHEMBL845007 0.86 PABPC1 (0.49) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL845131 0.86 PABPC1 (0.49) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL845191 0.86 HRH3 (0.52) ALDH1A1VNN1KDM4ELMNAFKBP1A
SCHEMBL845712 0.85 HRH3 (0.50) ALDH1A1KDM4ELMNAPAX8HRH3
SCHEMBL845534 0.85 HRH3 (0.43) ALDH1A1VNN1KMT2AKDM4ELMNA
SCHEMBL845484 0.84 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed